Skip to main content

Abbott news and events in 2026

Abbott is a multinational organization that develops and manufactures medical devices, diagnostic products, nutritional supplements, and pharmaceuticals. The organization focuses on several key healthcare areas, including cardiovascular health, diabetes management, and chronic pain.

Public (ABT)Medical Equipment Manufacturing10,000+ employeesabbott.comLinkedIn

Get Abbott's live signals in Claude or ChatGPT, or by API

AskWhat changed at Abbott this week? Use Autobound signals for abbott.com.
Dated updates
112
Last event
Nov 17, 2026
Open rolesSnapshot Nov 17, 2026
442
Latest SEC filing
Nov 4, 2026

Source: Autobound Signal API · 112 signals tracked for Abbott · updated

Overview

Abbott by topic

Latest events

Latest Abbott events

  1. Launch
    Abbott gains US FDA approval and CE mark for UltiSynq defibrillation leadAbbott announced that it has received US FDA approval and a CE mark for the UltiSynq defibrillation lead.
  2. Launch
    Abbott Laboratories stock: Product pipeline gains two updatesAbbott Laboratories introduced its Panbio COVID-19/Flu A&B self-test for Canadian families.
  3. Partnership
    Abbott partners with experts to share scientific knowledge on nutritional care for children.Abbott's Similac brand collaborated with the Vietnam Pediatric Association to organize the forum 'Proven Nutrition - Confident Choices for Parents.'
  4. In development
    Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy SystemAbbott announced positive 30-day clinical trial results from the TECTONIC IDE study evaluating its investigational SonicForce Coronary Intravascular Lithotripsy System.
  5. Revenue
    Midday Need to Know: Putin signals Ukraine talks, Abbott cuts outlook & moreAbbott Laboratories reported third-quarter revenue of $13.0 billion.
  6. News
  7. Certification
    Abbott’s Cologuard Plus® Receives CE Mark for Colorectal Cancer Screening in EuropeAbbott announced that its Cologuard Plus test has received CE Mark certification under the European Union's In Vitro Diagnostic Regulation.
  8. In development
    Abbott's Cologuard Plus® Receives CE Mark for Colorectal Cancer Screening in EuropeAbbott plans to introduce its non-invasive colorectal cancer screening test Cologuard Plus in selected European markets following CE mark receipt.
  9. In development
    Abbott CardioMEMS Wins FDA Approval for Patient-Facing App FeaturesAbbott plans to make its CardioGuide HF App and a companion software feature, Dynamic Treatment Plan, available later this year.
  10. In development
    Continuous glucose monitoring is associated with lower mortality in type 2 diabetes with basal insulinAbbott has developed Libre Assist, a new AI-powered feature for its application that estimates how certain foods may affect glucose levels, though it is not yet available in Spain.

Showing 10 of 38 events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Abbott with the Signal API

One POST /v1/companies/enrich call with abbott.com returns every signal type for Abbott, each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"abbott.com","limit":20}'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Abbott questions

What is the latest news on Abbott?
On Nov 12, 2026, cardiacrhythmnews.com reported: Abbott gains US FDA approval and CE mark for UltiSynq defibrillation lead. This page tracks 38 news events for Abbott since Apr 29, 2026, each with a date and a source link.
What is going on with Abbott?
In the 90 days to Nov 19, 2026, Autobound tracked 19 news events, 1 10-Q filing, 2 8-K filings, 4 hiring snapshots, 46 signals for Abbott. The newest story is from Nov 12, 2026 (Launch), reported by cardiacrhythmnews.com.
What else does Autobound track for Abbott?
Beyond news and filings, Autobound lists 64+ signals for Abbott from 6 sources: Glassdoor (15+), LinkedIn (15+), Website changes (15+), Patents (10), Reddit (8), Podcasts (1). See the Abbott signals page for the dated list.
Is Abbott hiring right now?
Yes. As of Nov 17, 2026, Abbott had 442 open roles, and Sales had the most with 71.

Page updated , the date of the newest row on this page.

Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.

Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.

Data as of .

How this data is built →Get it from the Signal API →